(Q73487830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

H B Ravivarapu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K L Moyer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R L Dunn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pharmaceutics

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

181-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Biodegradable microspheres in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900371-3

7 January 2021

10.1016/S0378-5173(99)00371-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692642%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference